高国全
高国全，男，一九六五年出生，现任中山大学中山医学院生物化学教研室主任，中国生物化学和分子生物学学会理事，广东省生物化学和分子生物学学会常务理事、秘书长。1997年6月 在中山医科大学获得医学（生物化学专业）博士学位；1999年晋升副教授；2004年晋升教授、博士生导师并获中山大学教师特别津贴，入选教育部首届“新世纪优秀人才”（2004年），入选广东省高等学校“千百十工程”培养对象。
主编人民卫生出版社规划教材护理本科《生物化学》、参加人民卫生出版社规划教材《医学分子生物学》的编写；负责国家级继续医学项目“疾病的分子生物学基础”；中山大学精品课程“生物化学与分子生物学”负责人。
1999.1-2002.5期间，在美国进行博士后研究工作并晋升为研究助理教授，研究糖尿病视网膜病的分子机制和治疗，成果发表在国际著名杂志上，如Diabetes , Journal of Biological Chemistry，FASEB Journal 等。
2002年6月回国后，先后获得中山大学985学科建设基金200万元，组建了先进的分子生物学实验室，建立了一支结构合理、基础扎实、积极进取的科研队伍。研究方向为：病理性血管增生的生化改变、分子机制及血管增生性疾病的生物治疗。课题组成员包括副教授1名，副主任技师1名，讲师3名，在读博士生9名、硕士生6名。已毕业博士2名、硕士3名。截至目前已获得国家自然科学基金（3项，70万）、CMB学者项目（5万美元）、教育部新世纪优秀人才支持计划（50万）、广东省科技攻关重大专项（2项，40万）、广东省自然科学基金团队项目（150万，核心成员）、广东省自然科学基金面上项目（10万，2项）、广州市科技攻关重点项目（2项，50万）、广东省医学科学基金（3.5万，4项）等基金近300万元的资助，研究工作进展顺利，已发表SCI论文10篇（通讯作者3篇，第一作者1篇），中文论文10篇，获省级科技进步三等奖一项，申请发明专利一项。
人生格言：人生最好的朋友和最大的敌人都是自己，能够驾驭自己就能驾驭人生。
给学生的一句话：勤奋和思考是从事科学研究必备的条件。
近五年SCI论文:
1. Xia Yang, Rui Cheng, Chaoyang Li,Weibin Cai, Jian-xing Ma, Qianping Liu, Zhonghan Yang, Zhihong Song, Zuguo Liu, and Guoquan Gao (corresponding author). Kringle 5 of human plasminogen suppresses hepatocellular carcinoma growth both in grafted and xenografted mice by anti-angiogenic activity. Cancer Biology & Therapy, 5(4):399-405, 2006. (Impact factor 3.3)
2. Qingsong Wang, Xia Yang, Zhonghan Yang, Guoquan Gao (corresponding author). A novel method for expression and purification of human Pigment Epithelium-derived Factor with biological activities in Escherichia coli. Preparative Biochemistry & Biotechnology, 36(2):127-138, 2006. (Impact factor 1.0)
3. Weibin Cai, Jianfang Ma, Chaoyang Li, Zhonghan Yang, Xia Yang, Wei Liu, Zuguo Liu, Mintao Li, and Guoquan Gao (corresponding author). Enhanced anti-angiogenic effect of a deletion mutant of plasminogen kringle 5 on neovascularization. J Cell Biochem, 96(6):1254-1261, 2005. (Impact factor 3.5)
4. Gao G, Shao C., Zhang S.X., Dudley A., Fant J, and Ma J-x. Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage. Diabetologia, 46,689-698, 2003. (Impact factor 5.7)
5. Gao G, Li Y, Fant J, Becerra SP, Crosson C and Ma J-x. Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium--derived factor in brown norway and sprague dawley rats contributing to different susceptibilities to retinal neovascularization. Diabetes, 51(4), 1218-1225, 2002. (Impact factor 9.1)
6. Gao G, Li Y, Gee S, Dudley A, Fant J, Crosson C and Ma J-x. Down-regulation of endogenous VEGF and up-regulation of PEDF: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5. J Biol Chem, 277(11), 9492-9497, 2002. (Impact factor 7.7)
7. Gao G and Ma J-x. Tipping the balance for angiogenic disorders. Drug Discovery Today, 7(3), 171-172, 2002. (Impact factor 4.1)
8. Gao G, Li Y, Zhang D, Gee S, Crosson CE and Ma J-x. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett, 489,270-276, 2001. (Impact factor 3.7)
9. Yousufzai SYK, Gao G, and Abdel-Latif AA. Mitogen-activated protein kinase inhibitors suppress prostaglandin F2a-induced myosin-light chain phosphorylation and contraction in iris sphincter smooth muscle. Eur J Pharmacol, 407, 17-26, 2000. (Impact factor 2.2)
10. Zhang D, Kaufman PL, Gao G, Saunders RA, and Ma J-x. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats. Diabetologia, 44,757-765, 2001. (Impact factor 5.7)
11. Jin J, Guan M, Sima J, Gao G, Zhang M, Liu Z, Fant J and Ma J-x. Decreased pigment epithelium-derived factor and increased Vascular endothelial growth factor in pterygia. Cornea, 22(5):473-477, 2003. (Impact factor 1.4)
12. Zhang S.X., Sima J, Shao C., Fant J, Chen Y, Rohrer B, Gao G, and Ma J-x. Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes. Diabetologia, 47(1), 124-131, 2004. (Impact factor 5.7)
13. Xie Y., Liu Y., Ma C., Yuan Z., Wang W., Zhu Z., Gao G., Liu X., Yuan H., Chen Y., Huang S., Wang X., Zhu X., Wang X., Mao Z., and Li M. Indirubin-3’-oxime inhibits c-Jun NH2-terminal kinase: anti-apoptotic effect in cerebellar granule neurons. Neuroscience Letters, 367:355-359, 2004. (Impact factor 2.1)
14. Zhang Z., Ma J-x., Gao G., Li C., Luo L., Zhang M., Chen J. and Liu, Z. Plasminogen kringle 5 inhibits alkali burn-induced corneal neovascularization. Invest. Ophthalmol. Vis. Sci., 46:4062-4071, 2005. (Impact factor 3.58)
15.Zhang, S.X., Wang, J.J., Gao, G., Shao, C. Mott, R., Longeras, R. and Ma, J-x. Pigment epithelium-derived factor (PEDF) is an endogenous anti-inflammatory factor. FASEB J., 20(2):32-35,2006. (Impact factor 6.82)
16.Zhang, S.X., Wang, J.J., Gao, G., Park, K. and Ma, J-x. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol., 37(1):1-12,2006. (Impact factor 3.85)